Category B. Emtricitabine-tenofovir has been assigned to pregnancy category b by the fda. Animal studies have failed to reveal evidence of embryofetal toxicity or teratogenicity. There are no controlled data in human pregnancy. However, emtricitabine-tenofovir has been evaluated in a limited number of women during pregnancy and postpartum.
Yes. Truvada (emtricitabine and tenofovir) is a pregnancy category b drug, meaning generally safe in pregnancy. However, it is unsafe in breastfeeding.
Yes. Hiv medications are very important to continue during pregnancy so as to not only improve your health but also studies show that it reduces the risk that you will pass on HIV to your child. The medications can be co-managed by your infectious disease doctor and your ob, usually a high-risk one called a perinatologist.
Bad side effect. When pregnant or breast feeding, why take a drug that has a 16% asthenia side effect incidence?